Review of the clinical and biologic aspects of human papillomavirus- positive squamous cell carcinomas of the head and neck

International Journal of Radiation Oncology Biology Physics

Volumn 88, Issue 4, 2014, Pages 761-770

  Blitzer, Grace C ^a   Smith, Molly A ^a   Harris, Stephen L ^b   Kimple, Randall J ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

^b Radiation Oncology Associates PA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOLOGY;

CELLULAR FUNCTION; CLINICAL CHARACTERISTICS; CLINICAL PRACTICES; CLINICAL TRIAL; HUMAN PAPILLOMAVIRUS; NATURAL HISTORY; SQUAMOUS CELL CARCINOMA; TUMOR DEVELOPMENT;

ONCOLOGY;

CARBOPLATIN; CETUXIMAB; CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; PACLITAXEL; PROTEIN E7; TRANSCRIPTION FACTOR E2F; WART VIRUS VACCINE;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARCINOGENESIS; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; TUMOR MICROENVIRONMENT; UTERINE CERVIX CANCER; VERRUCA VULGARIS; VIRUS DETECTION; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; CLINICAL TRIALS AS TOPIC; HEAD AND NECK NEOPLASMS; HUMANS; MOUTH DISEASES; ONCOGENES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84895771427     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.08.029     Document Type: Review

References (91)

1. J. Ferlay, H.R. Shin, and F. Bray et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
2. J. Decker, and J.C. Goldstein Risk factors in head and neck cancer N Engl J Med 306 1982 1151 1155
3. A.K. Chaturvedi, E.A. Engels, and W.F. Anderson et al. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States J Clin Oncol 26 2008 612 619
4. K.K. Ang, J. Harris, and R. Wheeler et al. Human papillomavirus and survival of patients with oropharyngeal cancer N Engl J Med 363 2010 24 35
5. C. Fakhry, W.H. Westra, and S. Li et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial J Natl Cancer Inst 100 2008 261 269
6. N.G. Shah, T.I. Trivedi, and R.A. Tankshali et al. Prognostic significance of molecular markers in oral squamous cell carcinoma: A multivariate analysis Head Neck 31 2009 1544 1556
7. N. Reimers, H.U. Kasper, and S.J. Weissenborn et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer Int J Cancer 120 2007 1731 1738
8. P.M. Weinberger, Z. Yu, and B.G. Haffty et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis J Clin Oncol 24 2006 736 747
9. D. Rischin, R.J. Young, and R. Fisher et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial J Clin Oncol 28 2010 4142 4148
10. H. Mellin, L. Dahlgren, and E. Munck-Wikland et al. Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer Int J Cancer 102 2002 152 158
11. K. Lindel, K.T. Beer, and J. Laissue et al. Human papillomavirus positive squamous cell carcinoma of the oropharynx: A radiosensitive subgroup of head and neck carcinoma Cancer 92 2001 805 813
12. L. Licitra, F. Perrone, and P. Bossi et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma J Clin Oncol 24 2006 5630 5636
13. P. Lassen The role of human papillomavirus in head and neck cancer and the impact on radiotherapy outcome Radiother Oncol 95 2010 371 380
14. M.R. Posner, J.H. Lorch, and O. Goloubeva et al. Survival and human papillomavirus in oropharynx cancer in TAX 324: A subset analysis from an international phase III trial Ann Oncol 22 2011 1071 1077
15. A.K. Chaturvedi, E.A. Engels, and R.M. Pfeiffer et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States J Clin Oncol 29 2011 4294 4301
16. R.E. Shope, and E.W. Hurst Infectious papillomatosis of rabbits: With a note on the histopathology J Exp Med 58 1933 607 624
17. P.S. Moore, and Y. Chang Why do viruses cause cancer? Highlights of the first century of human tumour virology Nat Rev Cancer 10 2010 878 889
18. M. Durst, L. Gissmann, and H. Ikenberg et al. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions Proc Natl Acad Sci U S A 80 1983 3812 3815
19. J.A. Suzich, S.J. Ghim, and F.J. Palmer-Hill et al. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas Proc Natl Acad Sci U S A 92 1995 11553 11557
20. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans Human papillomaviruses IARC Monogr Eval Carcinog Risks Hum 90 2007 1 636
21. C.M. Hebner, and L.A. Laimins Human papillomaviruses: Basic mechanisms of pathogenesis and oncogenicity Rev Med Virol 16 2006 83 97
22. C.A. Horvath, G.A. Boulet, and V.M. Renoux et al. Mechanisms of cell entry by human papillomaviruses: An overview Virol J 7 2010 11
23. G.L. Knight, A.G. Pugh, and E. Yates et al. A cyclin-binding motif in human papillomavirus type 18 (HPV18) E1̂E4 is necessary for association with CDK-cyclin complexes and G2/M cell cycle arrest of keratinocytes, but is not required for differentiation-dependent viral genome amplification or L1 capsid protein expression Virology 412 2011 196 210
24. M. Scheffner, B.A. Werness, and J.M. Huibregtse et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 Cell 63 1990 1129 1136
25. K. Munger, B.A. Werness, and N. Dyson et al. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product EMBO J 8 1989 4099 4105
26. D. DiMaio, and D. Mattoon Mechanisms of cell transformation by papillomavirus E5 proteins Oncogene 20 2001 7866 7873
27. L.T. Chow, T.R. Broker, and B.M. Steinberg The natural history of human papillomavirus infections of the mucosal epithelia APMIS 118 2010 422 449
28. S. Cheng, D.C. Schmidt-Grimminger, and T. Murant et al. Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes Genes Dev 9 1995 2335 2349
29. S. Song, A. Liem, and J.A. Miller et al. Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis Virology 267 2000 141 150
30. P. Indovina, E. Marcelli, and N. Casini et al. Emerging roles of RB family: New defense mechanisms against tumor progression J Cell Physiol 228 2013 525 535
31. X. Fan, Y. Liu, and S.A. Heilman et al. Human papillomavirus E7 induces rereplication in response to DNA damage J Virol 87 2013 1200 1210
32. N. Agrawal, M.J. Frederick, and C.R. Pickering et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1 Science 333 2011 1154 1157
33. N. Stransky, A.M. Egloff, and A.D. Tward et al. The mutational landscape of head and neck squamous cell carcinoma Science 333 2011 1157 1160
34. S. Duensing, L.Y. Lee, and A. Duensing et al. The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle Proc Natl Acad Sci U S A 97 2000 10002 10007
35. A. Duensing, Y. Liu, and M. Tseng et al. Cyclin-dependent kinase 2 is dispensable for normal centrosome duplication but required for oncogene-induced centrosome overduplication Oncogene 25 2006 2943 2949
36. P. Finzer, A. Aguilar-Lemarroy, and F. Rosl The role of human papillomavirus oncoproteins E6 and E7 in apoptosis Cancer Lett 188 2002 15 24
37. E.A. White, R.E. Kramer, and M.J. Tan et al. Comprehensive analysis of host cellular interactions with human papillomavirus E6 proteins identifies new E6 binding partners and reflects viral diversity J Virol 86 2012 13174 13186
38. K.W. Huh, J. DeMasi, and H. Ogawa et al. Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600 Proc Natl Acad Sci U S A 102 2005 11492 11497
39. M.L. Gillison, W.M. Koch, and R.B. Capone et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers J Natl Cancer Inst 92 2000 709 720
40. A.G. Schache, T. Liloglou, and J.M. Risk et al. Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: Sensitivity, specificity, and prognostic discrimination Clin Cancer Res 17 2011 6262 6271
41. C.L. Satterwhite, E. Torrone, and E. Meites et al. Sexually transmitted infections among US women and men: Prevalence and incidence estimates, 2008 Sex Transm Dis 40 2013 187 193
42. R.K. Pickard, W. Xiao, and T.R. Broutian et al. The prevalence and incidence of oral human papillomavirus infection among young men and women, aged 18-30 years Sex Transm Dis 39 2012 559 566
43. M.L. Gillison, T. Broutian, and R.K. Pickard et al. Prevalence of oral HPV infection in the United States, 2009-2010 JAMA 307 2012 693 703
44. G. D'Souza, Y. Agrawal, and J. Halpern et al. Oral sexual behaviors associated with prevalent oral human papillomavirus infection J Infect Dis 199 2009 1263 1269
45. A.E. Sanders, G.D. Slade, and L.L. Patton National prevalence of oral HPV infection and related risk factors in the U.S. adult population Oral Dis 18 2012 430 441
46. K. Louvanto, J. Rautava, and J. Willberg et al. Genotype-specific incidence and clearance of human papillomavirus in oral mucosa of women: A six-year follow-up study PLoS One 8 2013 e53413
47. A.R. Giuliano, J.H. Lee, and W. Fulp et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): A cohort study Lancet 377 2011 932 940
48. S.H. Mooij, H.J. Boot, and A.G. Speksnijder et al. Oral human papillomavirus infection in HIV-negative and HIV-infected men who have sex with men: The HIV & HPV in MSM (H2M) study AIDS 27 2013 2117 2128
49. K. Kero, J. Rautava, and K. Syrjanen et al. Oral mucosa as a reservoir of human papillomavirus: Point prevalence, genotype distribution, and incident infections among males in a 7-year prospective study Eur Urol 62 2012 1063 1070
50. Committee on Infectious Diseases HPV vaccine recommendations Pediatrics 129 2012 602 605
51. Centers for Disease Control and Prevention National and state vaccination coverage among adolescents aged 13-17 years - United States, 2011 MMWR Morb Mortal Wkly Rep 61 2012 671 677
52. A.J. Kimple, A.D. Torres, and R.Z. Yang et al. HPV-associated head and neck cancer: Molecular and nano-scale markers for prognosis and therapeutic stratification Sensors (Basel) 12 2012 5159 5169
53. M.H. Schiffman, H.M. Bauer, and A.T. Lorincz et al. Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA J Clin Microbiol 29 1991 573 577
54. A.D. Singhi, and W.H. Westra Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience Cancer 116 2010 2166 2173
55. D. Caussy, W. Orr, and A.D. Daya et al. Evaluation of methods for detecting human papillomavirus deoxyribonucleotide sequences in clinical specimens J Clin Microbiol 26 1988 236 243
56. C.J. Kim, J.K. Jeong, and M. Park et al. HPV oligonucleotide microarray-based detection of HPV genotypes in cervical neoplastic lesions Gynecol Oncol 89 2003 210 217
57. S.S. Seo, Y.S. Song, and J.W. Kim et al. Good correlation of HPV DNA test between self-collected vaginal and clinician-collected cervical samples by the oligonucleotide microarray Gynecol Oncol 102 2006 67 73
58. J. Thomas, and T. Primeaux Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus-associated head and neck squamous cell carcinoma? Ann Diagn Pathol 16 2012 91 99
59. C.A. Fischer, M. Kampmann, and I. Zlobec et al. p16 expression in oropharyngeal cancer: Its impact on staging and prognosis compared with the conventional clinical staging parameters Ann Oncol 21 2010 1961 1966
60. S.L. Harris, L.B. Thorne, and W.T. Seaman et al. Association of p16(INK4a) overexpression with improved outcomes in young patients with squamous cell cancers of the oral tongue Head Neck 33 2011 1622 1627
61. N.G. Chau, B. Perez-Ordonez, and K. Zhang et al. The association between EGFR variant III, HPV, p16, c-MET, EGFR gene copy number and response to EGFR inhibitors in patients with recurrent or metastatic squamous cell carcinoma of the head and neck Head Neck Oncol 3 2011 11
62. V. Ko, R.H. Tambouret, and D.L. Kuebler et al. Human papillomavirus testing using hybrid capture II with SurePath collection: Initial evaluation and longitudinal data provide clinical validation for this method Cancer 108 2006 468 474
63. C.C. Ginocchio, D. Barth, and F. Zhang Comparison of the Third Wave Invader human papillomavirus (HPV) assay and the digene HPV hybrid capture 2 assay for detection of high-risk HPV DNA J Clin Microbiol 46 2008 1641 1646
64. D.F. Kurtycz, M. Smith, and R. He et al. Comparison of methods trial for high-risk HPV Diagn Cytopathol 38 2010 104 108
65. M. Steinau, D.C. Swan, and E.R. Unger Type-specific reproducibility of the Roche linear array HPV genotyping test J Clin Virol 42 2008 412 414
66. L. Barzon, V. Militello, and E. Lavezzo et al. Human papillomavirus genotyping by 454 next generation sequencing technology J Clin Virol 52 2011 93 97
67. C. Conway, R. Chalkley, and A. High et al. Next-generation sequencing for simultaneous determination of human papillomavirus load, subtype, and associated genomic copy number changes in tumors J Mol Diagn 14 2012 104 111
68. C.C. Wang, C.H. Lai, and Y.T. Huang et al. HPV genotypes predict survival benefits from concurrent chemotherapy and radiation therapy in advanced squamous cell carcinoma of the cervix Int J Radiat Oncol Biol Phys 84 2012 e499 e506
69. C.H. Lai, C.J. Chang, and H.J. Huang et al. Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery J Clin Oncol 25 2007 3628 3634
70. P.K. Goon, M.A. Stanley, and J. Ebmeyer et al. HPV & head and neck cancer: A descriptive update Head Neck Oncol 1 2009 36
71. T. Rieckmann, S. Tribius, and T.J. Grob et al. HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity Radiother Oncol 107 2013 242 246
72. R.J. Kimple, M.A. Smith, and G.C. Blitzer et al. Increased radiation sensitivity in HPV-positive head and neck cancer is due to residual p53 activity Cancer Research 73 2013 4791 4800
73. C.C. Ragin, and E. Taioli Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta-analysis Int J Cancer 121 2007 1813 1820
74. B. O'Sullivan, S.H. Huang, and L.L. Siu et al. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis J Clin Oncol 31 2013 543 550
75. M.L. Gillison, Q. Zhang, and R. Jordan et al. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer J Clin Oncol 30 2012 2102 2111
76. J.H. Maxwell, B. Kumar, and F.Y. Feng et al. Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence Clin Cancer Res 16 2010 1226 1235
77. G.J. Hanna, R.I. Haddad, and J.H. Lorch Induction chemotherapy for locoregionally advanced head and neck cancer: Past, present, future? Oncologist 18 2013 288 293
78. J.A. Bonner, P.M. Harari, and J. Giralt et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 2006 567 578
79. J. Vermorken, J. Stohlmacher, and K. Oliner et al. Safety and efficacy of panitumumab (pmab) in HPV positive (+) and HPV begative (-) recurrent/metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): Analysis of the phase 3 SPECTRUM trial Eur J Cancer 47 Suppl. 2 2011 13
80. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: The next generation Cell 144 2011 646 674
81. W.C. Spanos, P. Nowicki, and D.W. Lee et al. Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer Arch Otolaryngol Head Neck Surg 135 2009 1137 1146
82. M. Heusinkveld, R. Goedemans, and R.J. Briet et al. Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer Int J Cancer 131 2012 E74 E85
83. A. Turksma, H. Bontkes, and H. van den Heuvel et al. Effector memory T-cell frequencies in relation to tumour stage, location and HPV status in HNSCC patients Oral Dis 19 2013 577 584
84. C. Badoual, S. Hans, and N. Merillon et al. PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer Cancer Res 73 2013 128 138
85. D.W. Vermeer, W.C. Spanos, and P.D. Vermeer et al. Radiation-induced loss of cell surface CD47 enhances immune-mediated clearance of human papillomavirus-positive cancer Int J Cancer 133 2013 120 129
86. J. Overgaard, J.G. Eriksen, and M. Nordsmark et al. Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: Results from the DAHANCA 5 randomised double-blind placebo-controlled trial Lancet Oncol 6 2005 757 764
87. C.S. Kong, B. Narasimhan, and H. Cao et al. The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas Int J Radiat Oncol Biol Phys 74 2009 553 561
88. P. Lassen, J.G. Eriksen, and S. Hamilton-Dutoit et al. HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer Radiother Oncol 94 2010 30 35
89. L.S. Mortensen, J. Johansen, and J. Kallehauge et al. FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: Results from the DAHANCA 24 trial Radiother Oncol 105 2012 14 20
90. J.F. Jansen, D.L. Carlson, and Y. Lu et al. Correlation of a priori DCE-MRI and (1) H-MRS data with molecular markers in neck nodal metastases: Initial analysis Oral Oncol 48 2012 717 722
91. R.J. Kimple, P. Harari, and A.D. Torres et al. Development and characterization of HPV-positive and HPV-negative head and neck squamous cell carcinoma tumorgrafts Clinical Cancer Research 19 2013 855 864